Abiomed to Present at Cowen and Company 33rd Annual Health Care Conference
* Reuters is not responsible for the content in this press release.
http://pdf.reuters.com/htmlnews/8knews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130227:nGNXUXGESa DANVERS, Mass., Feb. 27, 2013 (GLOBE NEWSWIRE) -- Abiomed, Inc http://www.globenewswire.com/newsroom/ctr?d=10023201&l=1&a=Abiomed%2C%20Inc&u=http%3A%2F%2Fwww.abiomed.com%2F . (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Susan V. Lisa, Senior Director, Investor Relations and Corporate Development, will present at the Cowen and Company 33rd Annual Health Care Conference on Wednesday, March 6, 2013 at 10:40 a.m. ET. The conference will be held at the Boston Marriott Copley Place in Boston, Massachusetts. ABOUT ABIOMED Based in Danvers, Massachusetts, Abiomed, Inc., is a leading provider of medical devices that provide circulatory support. Our products are designed to enable the heart to rest by improving blood flow and/or performing the pumping of the heart. For additional information please visit: www.abiomed.com http://www.globenewswire.com/newsroom/ctr?d=10023201&l=3&a=www.abiomed.com&u=http%3A%2F%2Fwww.abiomed.com%2F The Abiomed logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=13564 http://www.globenewswire.com/newsroom/ctr?d=10023201&l=4&u=http%3A%2F%2Fwww.globenewswire.com%2Fnewsroom%2Fprs%2F%3Fpkgid%3D13564 FORWARD-LOOKING STATEMENTS This release contains forward-looking statements, including statements regarding development of Abiomed's existing and new products, the Company's progress toward commercial growth, and future opportunities and expected regulatory approvals. The Company's actual results may differ materially from those anticipated in these forward-looking statements based upon a number of factors, including uncertainties associated with development, testing and related regulatory approvals, including the potential for future losses, complex manufacturing, high quality requirements, dependence on limited sources of supply, competition, technological change, government regulation, litigation matters, future capital needs and uncertainty of additional financing, and other risks and challenges detailed in the Company's filings with the Securities and Exchange Commission, including the most recently filed Annual Report on Form 10-K and quarterly report on Form 10-Q. Readers are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date of this release. The Company undertakes no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances that occur after the date of this release or to reflect the occurrence of unanticipated events. CONTACT: For further information please contact: Susie Lisa, CFA Senior Director, Investor Relations and Corporate Development 978-646-1590 firstname.lastname@example.org Aimee Maillett Corporate Communications Manager 978-646-1553 email@example.com
- Obama condemns killing of reporter, U.S. hits militants in Iraq |
- Gaza war rages on, Hamas says Israel tried to kill its military chief |
- Four beheaded corpses found in Egypt's Sinai: security sources
- Father of Texas 'affluenza' teen arrested for impersonating police officer
- Islamic State opens new anti-U.S. front with beheading video